Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Aug 1;13(8):a041525.
doi: 10.1101/cshperspect.a041525.

Electronic Retinal Prostheses

Daniel Palanker  1
Affiliations
Review

Electronic Retinal Prostheses

Daniel Palanker. Cold Spring Harb Perspect Med. .

Abstract

Retinal prostheses are a promising means for restoring sight to patients blinded by photoreceptor atrophy. They introduce visual information by electrical stimulation of the surviving inner retinal neurons. Subretinal implants target the graded-response secondary neurons, primarily the bipolar cells, which then transfer the information to the ganglion cells via the retinal neural network. Therefore, many features of natural retinal signal processing can be preserved in this approach if the inner retinal network is retained. Epiretinal implants stimulate primarily the ganglion cells, and hence should encode the visual information in spiking patterns, which, ideally, should match the target cell types. Currently, subretinal arrays are being developed primarily for restoration of central vision in patients impaired by age-related macular degeneration (AMD), while epiretinal implants-for patients blinded by retinitis pigmentosa, where the inner retina is less preserved. This review describes the concepts and technologies, preclinical characterization of prosthetic vision and clinical outcomes, and provides a glimpse into future developments.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Ahuja AK, Dorn JD, Caspi A, McMahon MJ, Dagnelie G, Dacruz L, Stanga P, Humayun MS, Greenberg RJ. 2011. Blind subjects implanted with the Argus II retinal prosthesis are able to improve performance in a spatial-motor task. Br J Ophthalmol 95: 539–543. 10.1136/bjo.2010.179622 - DOI - PMC - PubMed
    1. Ahuja AK, Yeoh J, Dorn JD, Caspi A, Wuyyuru V, McMahon MJ, Humayun MS, Greenberg RJ, Dacruz L. 2013. Factors affecting perceptual threshold in Argus II retinal prosthesis subjects. Transl Vis Sci Technol 2: 1. 10.1167/tvst.2.4.1 - DOI - PMC - PubMed
    1. Ayton LN, Blamey PJ, Guymer RH, Luu CD, Nayagam DA, Sinclair NC, Shivdasani MN, Yeoh J, McCombe MF, Briggs RJ, et al. 2014. First-in-human trial of a novel suprachoroidal retinal prosthesis. PLoS ONE 9: e115239. 10.1371/journal.pone.0115239 - DOI - PMC - PubMed
    1. Ayton LN, Rizzo JF, Bailey IL, Colenbrander A, Dagnelie G, Geruschat DR, Hessburg PC, McCarthy CD, Petoe MA, Rubin GS, et al. 2020. Harmonization of outcomes and vision endpoints in vision restoration trials: recommendations from the International HOVER Taskforce. Transl Vis Sci Technol 9: 25. 10.1167/tvst.9.8.25 - DOI - PMC - PubMed
    1. Beauchamp MS, Oswalt D, Sun P, Foster BL, Magnotti JF, Niketeghad S, Pouratian N, Bosking WH, Yoshor D. 2020. Dynamic stimulation of visual cortex produces form vision in sighted and blind humans. Cell 181: 774–783.e5. 10.1016/j.cell.2020.04.033 - DOI - PMC - PubMed

Publication types

LinkOut - more resources

-